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Abstract Neuropeptides are essential for the regulation of appetite. Here we show that
neuropeptides could regulate feeding in mutants that lack neurotransmission from the motor
neurons that stimulate feeding muscles. We identified nlp-24 by an RNAi screen of 115 neuropeptide
genes, testing whether they affected growth. NLP-24 peptides have a conserved YGGXX sequence,
similar to mammalian opioid neuropeptides. In addition, morphine and naloxone respectively
stimulated and inhibited feeding in starved worms, but not in worms lacking NPR-17, which encodes
a protein with sequence similarity to opioid receptors. Opioid agonists activated heterologously
expressed NPR-17, as did at least one NLP-24 peptide. Worms lacking the ASI neurons, which
express npr-17, did not response to naloxone. Thus, we suggest that Caenorhabditis elegans has an
endogenous opioid system that acts through NPR-17, and that opioids regulate feeding via ASI
neurons. Together, these results suggest C. elegans may be the first genetically tractable
invertebrate opioid model.
DOI: 10.7554/eLife.06683.001

Introduction
Animal feeding behavior has been well studied because of its health relevance as well as its
fundamental physiological and ecological importance. Caenorhabditis elegans is a useful model
system for studying the genetic control of feeding (Avery, 2012). In C. elegans, feeding is dependent
on the pumping motion of the pharynx, which results in the ingestion of food, and whose rate is an
easily quantified measure of feeding. The pathways that control feeding are at least partly conserved
from worms to mammals.
Control of animal feeding is not simple. Multiple peripheral and central signals, neuropeptides
among them, modulate food intake. For example, α-melanocyte-stimulating hormone, a peptide
which activates MC3 and MC4 melanocortin receptors and inhibits food intake (Meister, 2007),
putative satiety signal peptide YY3–36 (PYY3–36) (Batterham et al., 2002), and cholecystokinin (Gibbs
et al., 1973) participate in the termination of meals in mammals. Galanin is a peptide that stimulates
feeding in satiated rats after intraventricular or intrahypothalamic injection. Opioids are also involved
in controlling food intake, and they have many other biological effects (e.g., analgesia, drug addiction,
and immune response). For example, the opioid agonist morphine increases food intake in mammals
while the opioid blocker, naloxone, significantly decreases food intake (Martin et al., 1963).
The opioid system is composed of μ-opioid receptors (MORs), δ-opioid receptors (DORs), and
κ-opioid receptors (KORs), and endogenous ligands for these receptors. Enkephalins, dynorphins, and
β-endorphin peptides are produced by proteolytic cleavage of large protein precursors known as
preproenkephalin, preprodynorphin, and proopiomelanocortin (POMC), respectively. These peptides
form the opioid family. All opioid peptides share a common N-terminal YGGF signature sequence,
which interacts with opioid receptors (Holtzman, 1974; Akil et al., 1998). Many researchers have
shown that the opilioid system modulates food intake. β-endorphin stimulates food intake when
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When and how much an animal eats is controlled by a complex web of signals that
are produced by the animal’s body and brain. Molecules called opioid neuropeptides are among
these signals, and act to control eating in mammals by binding to receptors in the brain and body.
These receptors can also bind to similar molecules called opiates (such as morphine); opiates are
amongst the oldest drugs used by humans and have diverse effects ranging from pain relief to
addiction. While the activities of opiates and opioid neuropeptides have been studied in mammals,
relatively little is known about opioid signaling in simpler animals.
The mechanisms behind many biological processes have been investigated using a worm called
C. elegans as a model system because it has a simple body plan and its genes can be altered easily.
The feeding behavior of C. elegans is no exception. This worm feeds by contracting and relaxing its
pharyngeal muscle to move food into its gut. When the worms sense that food is available, this
‘pharyngeal pumping’ is regulated by one type of nerve cell. Slow pharyngeal pumping also
continues in starved worms when food is not available, possibly to encourage them to eat new
potential sources of food. However, this slow pumping does not require the same type of nerve cell.
Cheong et al. hypothesized that the slow pumping in starved worms might depend on
neuropeptide signaling instead, and have now tested this idea using engineered worms that made
lower levels of a number of these molecules. The experiments uncovered a molecule called NLP-24
that promotes the slow pharyngeal pumping. This molecule is similar to opioid neuropeptides found
in mammals. Worms that made less NLP-24 than normal grew more slowly; this suggests that they
had problems feeding. Moreover, the levels of NLP-24 were found to increase in normal worms soon
after they were deprived of food. Further experiments revealed the identity of the receptor for this
molecule, which is also similar to mammalian opioid receptors.
The discovery that opioid signaling is involved in C. elegans’ feeding behavior may well, in future,
also help to identify new molecular players involved in opioid signaling. Further studies might also
help the search for ways to reduce the problematic side-effects that limit the usefulness of opiate
drugs as medicines.
DOI: 10.7554/eLife.06683.002

administrated directly into the VMH (ventromedial hypothalamus) (Grandison and Guidotti, 1977).
Selective agonists for the μ receptor (DAMGO), the δ receptor (DADLE), and the κ receptor (U50448)
also increase food intake (Tepperman and Hirst, 1983; Gosnell et al., 1986; Jackson and Cooper,
1986). Furthermore, β-endorphin levels are associated with overeating in genetically obese mice and
fa/fa rats (Margules et al., 1978). There is abundant pharmacological evidence that the opioid system
is present and controls feeding in both invertebrates and vertebrates (Harrison et al., 1994). A simple
invertebrate model system would be a useful starting point for understanding more complex ones.
Furthermore, it might shed light on the evolutionary origin of the opioid system. However, no opioid
system has yet been molecularly identified in invertebrates.
Peptide hormones and peptide neurotransmitters are well conserved from humans to invertebrates
(Kimura et al., 1997; Janssen et al., 2008b). Among the most conserved are those that signal nutritional
state and control feeding and metabolism—insulin is the best-known example. C. elegans has 115
neuropeptide genes encoding over 250 distinct neuropeptides (Li and Kim, 2008). However, the functions
of most neuropeptides remain unknown. Here we show that, like humans, C. elegans has opioid peptide
signals that regulate feeding. We found that morphine and naloxone, respectively, stimulate and inhibit
feeding in starved wild-type worms, but not in worms lacking the G-protein coupled receptor NPR-17. Our
genetic screens identified NLP-24-derived peptides as possible endogenous opioid ligands on which
feeding motions that occur in the absence of food may depend and NPR-17 as the opioid receptor on
which they act. To our knowledge this is the first genetically tractable invertebrate opioid model.

Results
Peptide signals control MC-independent pumping
In well-fed C. elegans, pharyngeal pumping, the motion of the feeding muscles, is mostly determined
by MC motor neuron activity in the pharynx (Raizen et al., 1995). The food stimulates the MC neuron,
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which fires at the beginning of each pump, triggering a muscle action potential that makes the muscle
contract. But a starved worm continually pumps at a low rate even in the absence of food. This
pumping does not require MC neurons. This MC-independent pumping makes worms viable without
MC, although they pump slowly, grow slowly, and are small and pale. We were curious how worms
continue to pump without MC.
In mammals, neuropeptides modulate food intake. Over 250 neuropeptides encoded by 115 genes
have been identified in C. elegans (Li and Kim, 2008). Most of their functions are still unknown. We
hypothesized that MC-independent pumping might depend on neuropeptide signaling. To test our
hypothesis, we made eat-2; egl-3 mutants, in which signals from both MC and neuropeptides are
disrupted. eat-2 encodes an acetylcholine receptor subunit specific to the MC → muscle synapse; thus
the mutants are functionally MC-minus (McKay et al., 2004). egl-3 encodes a protease necessary for
neuropeptide processing, and thus the mutant lacks most neuropeptides (Husson et al., 2006). egl-3
mutants pumped at the wild-type rate. However, eat-2; egl-3 mutants pumped only 1/3 as fast as eat2 mutants (Figure 1A). This result indicated that neuropeptides regulate pumping in the absence of
MC neuron activity.
To identify neuropeptides that regulate pumping in the absence of MC function, we performed an
RNAi (RNA interference) screen of neuropeptide genes. Because RNAi works less efficiently in the
nervous system than in other tissues, we first tested egl-3 RNAi efficiency in two genetic backgrounds
that enhance RNAi in neurons, rrf-3 and eri-1; lin-15b (Simmer et al., 2002; Wang et al., 2005). eat-2;
egl-3 mutants grow slowly compared to eat-2 due to their slow pumping rate, showing that we could
use growth rate as an indicator for the pumping defect. eat-2; eri-1; lin-15b mutants grew slowly after
egl-3 RNAi, whereas rrf-3; eat-2 did not. This suggested that eat-2; eri-1; lin-15b mutants are more
sensitive to RNAi in the cells that produce neuropeptides relevant to MC-independent pumping. Thus
we used eat-2; eri-1; lin-15b for the RNAi screen.
From the RNAi screen of 115 neuropeptide genes we found several that changed the growth rate
of eat-2; eri-1; lin-15b mutants. RNAi of five NLP (Neuropeptide-Like Proteins) family genes (nlp-2,
nlp-12, nlp-14, nlp-24, and nlp-34) and 2 INS (INSulin related) family genes (ins-34 and ins-39)
decreased growth rates compared to control (Supplementary file 1). Among these seven genes RNAi
of nlp-24 delayed growth most. To validate the RNAi results, we constructed eat-2; nlp-24 double
mutants and measured their pumping rate. As expected from RNAi results, the eat-2; nlp-24 mutants

Figure 1. MC neurons and neuropeptides redundantly control pumping rate. (A) Pumping rate in eat-2, egl-3
and eat-2; egl-3 mutants. egl-3 reduced pumping in eat-2 mutants. ***p < 0.001. (ANOVA + Tukey tests).
(B) nlp-3 suppressed pumping and nlp-24 stimulated pumping in eat-2 mutants. ***Different from eat-2,
p < 0.001 (ANOVA + Dunnett tests). In this and all figures, errors bars represent standard error.
DOI: 10.7554/eLife.06683.003
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had decreased pumping rates compared to eat-2 (Figure 1B). Interestingly, RNAi of nlp-3 and nlp-13
improved the growth rate of eat-2 mutants, suggesting that peptides encoded by these genes might
antagonize MC-independent pumping. Indeed, the eat-2; nlp-3 mutants have increased pumping
rates compared to eat-2. These results demonstrate that nlp-24 increases pumping and nlp-3
suppresses pumping in the absence of MC neuron activity. Because eat-2; nlp-24 mutants do not
pump as slowly as eat-2; egl-3 mutants (Figure 1A,B), we suggest that there may be other
neuropeptides that act together with nlp-24 to stimulate pumping in the absence of MC neuron
activity.
Based on these results we hypothesize that nlp-24 and nlp-3 regulate pumping rate in the absence
of food when MC is inactive.

NLP-24 regulates pumping under starvation conditions
In mammals, one major mode of neuropeptide regulation is control of mRNA levels (Brady et al.,
1990; Challis et al., 2003). Thus we measured the mRNA levels of nlp-3 and nlp-24 in well-fed and
starved worms. nlp-3 mRNA levels were unaffected, but the nlp-24 increased after a 3 hr starvation,
suggesting it plays a role in regulation of pumping during starvation (Figure 2A). Wild type worms
initially pump slowly when taken off food, but increase pumping rate gradually during several hours of
starvation (Avery and Horvitz, 1990). In confirmation, nlp-24 mutants showed a reduced pumping
rate compared to wild type after 1 hr of starvation, and this defect was rescued by a transgene that
encoded the wild-type copy of nlp-24 gene under control of its own promoter. Moreover, nlp-24
overexpression further increased the pumping rate in starved worms compared to non-transgenic
worms (Figure 2B). These results indicate that nlp-24 stimulates pumping during starvation. egl-3
mutants, which lack most active neuropeptides, also had decreased pumping during starvation
(Figure 2—figure supplement 1), showing that neuropeptides contribute to pumping during
starvation.
NLP-24 is predicted to be processed into peptides contain YGGY sequences either internally or at
the N-terminus (Nathoo et al., 2001; Janssen et al., 2008a) (Figure 2C). Comparing the sequence of
NLP-24 peptides with that of human neuropeptides, we noted that the YGGY sequences are similar to
the conserved YGGF sequence motif of endogenous opioids in humans (Snyder and Pasternak,
2003). Thus we hypothesize that nlp-24 potentially encodes endogenous opioids in C. elegans.
Although no C. elegans opioid signaling system has been reported, a study identified NPR-17, a G
protein coupled receptor, as most closely related to a predicted Brugia malayi ORL1 opioid receptorlike protein with 68% identity (Harris et al., 2010). They found that nlp-3, a neuropeptide gene, and
npr-17 regulated avoidance behavior, suggesting NLP-3 and NPR-17 together could mediate a signal
to control pain in C. elegans (Harris et al., 2010). In BLAST searches, we verified their finding further;
NPR-17 is similar to human nociceptin receptor (28% identity), MOR (23% identity), DOR (23%
identity) and to the KOR (24% identity) (Figure 2—figure supplement 2). Together these results
suggested that NLP-24 peptides and NPR-17 receptor constitute an endogenous opioid system in C.
elegans.

Opioids modulate pumping through NPR-17, a homolog of mammalian
opioid receptors
Because NLP-24 stimulated C. elegans pumping under starvation conditions and because previous
work and sequence homology suggested NPR-17 could be an opioid receptor, we tested whether
opiates affect pumping, and whether NPR-17 mediates these effects. First, we treated starved wild
type and npr-17 mutants with opioid agonist morphine and blocker naloxone and measured the
pumping rate. As predicted, morphine stimulated pumping whereas naloxone suppressed pumping in
wild type. Drugs get into intact worms inefficiently, both because the wild-type cuticle is poorly
permeable (Partridge et al., 2008) and because foreign chemicals are actively pumped out
(Broeks et al., 1996; Ardelli and Prichard, 2013). For instance, although 1 μM serotonin maximally
stimulates pumping in dissected pharynxes (Niacaris and Avery, 2003), roughly 10 mM is necessary
to produce similar effects in intact animals (Horvitz et al., 1982; Hobson et al., 2006; Raizen et al.,
2012). Thus we were not surprised that high concentrations of morphine (0.5 mM) and naloxone
(10 mM) were necessary to produce these effects. Specificity was demonstrated by the observation
that these effects were completely abolished by npr-17 mutations, showing that NPR-17 mediated the
effects, suggesting it could be an opioid receptor in C. elegans (Figure 3A,B). We tested two different
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Figure 2. nlp-24 stimulates pumping in starved worms. (A) nlp-3 and nlp-24 mRNA levels in well-fed and starved
worms. qRT-PCR was performed to assess mRNA expression. Normalized with ama-1. ***Different from well-fed, p <
0.001 (two-way ANOVA on Ct with Bonferroni correction). (B) Pumping rate after 1 hr starvation. nlp-24 stimulated
pumping during starvation. ***p < 0.001, N.S. not significant (ANOVA + Tukey tests). (C) NLP-24 and human
endogenous opioid peptides.
DOI: 10.7554/eLife.06683.004
The following figure supplements are available for figure 2:
Figure supplement 1. Neuropeptides stimulate pumping in starvation.
DOI: 10.7554/eLife.06683.005
Figure supplement 2. Phylogenetic analysis of opioid receptors.
DOI: 10.7554/eLife.06683.006
Figure supplement 3. nlp-3 pumping rate after 1 hr starvation.
DOI: 10.7554/eLife.06683.007
Figure supplement 4. Well-fed nlp-24 mutant pumping rate.
DOI: 10.7554/eLife.06683.008

alleles (tm3210 and tm3225) of npr-17 and both alleles gave the same results (Figure 3B and
Figure 3—figure supplement 1). Taken together these results indicate that opioids stimulate C.
elegans pumping and that NPR-17 might be a worm opioid receptor.
To further test whether npr-17 mediates nlp-24 action, we overexpressed nlp-24 in npr-17 mutants.
nlp-24 overexpression in the wild type background caused faster pumping under starvation conditions
as shown above. However, nlp-24 overexpressed in the npr-17 background did not increase the
pumping rate (Figure 4A). nlp-24; npr-17 double mutants also pumped at the same rate as npr-17
mutants (Figure 4B). These results indicate that NPR-17 is downstream of NLP-24 and are consistent
with the hypothesis that NPR-17 is a receptor for NLP-24-derived peptides to regulate pumping
during starvation.
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Figure 3. Opioids control pumping through npr-17. (A) Effect of morphine on pumping. (B) Effect of naloxone on pumping rate. Adult hermaphrodites
were starved for 1 hr and tested. Morphine stimulates pumping and naloxone inhibits it in wild-type worms; neither drug affects npr-17(tm3210) mutants.
***Different from 0 mM, p < 0.001; N.S. not significantly different from 0 mM (two-way ANOVA, concentration effect). The effects of morphine and
naloxone on wild-type are significantly different from their effects on npr-17, p < 0.001 (two-way ANOVA, genotype × concentration interaction).
DOI: 10.7554/eLife.06683.009
The following figure supplements are available for figure 3:
Figure supplement 1. Effect of naloxone on pumping rate in npr-17(tm3225) mutant worms.
DOI: 10.7554/eLife.06683.010
Figure supplement 2. Naloxone reduces the pumping rate of eat-2 mutants.
DOI: 10.7554/eLife.06683.011

Next we examined whether NLP-24 peptides indeed function as opioids and NPR-17 as an opioid
receptor using heterologous expression in HEK293 cells. We coexpressed NPR-17 in HEK293 cells with
the promiscuous G protein Gα15 and administered synthetic NLP-24 peptides. In this heterologous
system, only one of these peptides, GPYGYGamide, activated NPR-17 (Figure 5A), suggested that NLP24 encodes at least one NPR-17 ligand. We also tested agonists specific for mammalian opioid receptor
subtypes: loperamide for the MORs (DeHaven-Hudkins et al., 1999), SB205607 for the DORs (Fujii
et al., 2004), and U69593 for the KORs (Towett et al., 2006). NPR-17 was also activated by loperamide
and U69593 (Figure 5A). GPYGYGamide, loperamide, and U69593 activated NPR-17 in a dosedependent manner, and these responses were abrogated by naloxone (Figure 5B). These results
indicate that NPR-17 is an opioid receptor and NLP-24 peptide GPYGYGamide is a C. elegans opioid.
We then tested whether NLP-24 peptides can activate human opioid receptors. We individually
coexpressed each human opioid receptor in HEK293 cell with Gα15. We tested an agonist specific for
each receptor subtype in addition to NLP-24 peptides. Mu-type opioid receptor (MOR-1) and kappatype opioid receptor (KOR-1) responded only to YGGYGamide peptide, while delta-type opioid
receptor (DOR-1) did not respond to any NLP-24 peptide (Figure 6). Thus C. elegans has a peptide
that can activate human opioid receptors, predicted to be produced from the same precursor that
produces at least one ligand for the C. elegans opioid receptor NPR-17, which can also be activated
by vertebrate receptor-specific opioid agonists. These results suggested that C. elegans and
vertebrates share a conserved opioid system.

ASI neurons are required for opioid signaling and NPR-17 in ASI neurons
is sufficient for opioid signaling
npr-17 was shown to be expressed in ASI neurons (Harris et al., 2010), a pair of head sensory neurons
that regulate multiple food-related effects such as quiescence, dauer formation, and caloricrestriction-induced life span increase (Inoue and Thomas, 2000; Bishop and Guarente, 2007;
Gallagher et al., 2013b). Because the pumping rate regulated by nlp-24 is also food-related and the
receptor NPR-17 is known to be expressed in ASI, we tested whether ASI neurons are important for
opioid signaling. When we treated worms whose ASI neurons were genetically ablated with naloxone,
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Figure 4. nlp-24 regulates pumping through npr-17. (A) Overexpressed nlp-24 in npr-17 mutants did not stimulate
pumping. (B) In the npr-17 background, nlp-24 mutations have no effect on pumping rate in starved worms. (N.S. not
significant, Student’s t-test).
DOI: 10.7554/eLife.06683.012

there was no naloxone-induced reduction in pumping (Figure 7A). Thus the opioid blocker controlled
pumping through ASI neurons. Next, to examine whether ASI neurons are the site of action of NPR17, we expressed it in ASI using the ASI specific promoter, gpa-4. Expression of NPR-17 only in the
ASI neurons completely restored the pumping reduction induced by naloxone treatment (Figure 7B
and Figure 7—figure supplement 1). npr-17 is also expressed in intestine. We therefore also tested
the effect of naloxone on worms engineered to express NPR-17 only in the intestine (using the ges-1
promoter). These worms were not rescued (Figure 7B and Figure 7—figure supplement 1). Thus
NPR-17 in ASI mediated opioid signaling to regulate pumping during starvation.
While the insensitivity of npr-17 mutants to naloxone is consistent with NPR-17 being the naloxone
receptor, the sign of the effect was initially surprising. In the absence of drug, npr-17 mutants pumped at
the same rate as wild type, while they pumped faster than wild-type worms in the presence of naloxone.
This would suggest that naloxone is an agonist rather than a blocker, but this is inconsistent with the known
effect of naloxone of opioid receptors, as well as the measured effect on heterologously expressed NPR17 (Figure 5B). An alternate hypothesis is that npr-17 worms, having lacked the receptor all their lives, had
adapted to its absence. One of these adaptations was an increase in the basal pumping rate. In wild-type
worms, in contrast, NPR-17 had always been around supporting basal pumping. When we suddenly
removed this support by adding naloxone, the pumping rate went down. This hypothesis predicts that the
chronic effects of naloxone on wild type should resemble those of the mutation. We thus grew wild-type
worms to adulthood on naloxone, then measured the pumping rate after starvation either with or without
naloxone. As predicted, wild-type worms grown and tested in the presence of naloxone pumped at the
same rate as worms grown and tested without (Figure 7C). Furthermore, after chronic naloxone treatment
worms tested in its absence showed a withdrawal effect: they pumped slightly faster. These results are
consistent with the hypothesis that, in vivo as in vitro, naloxone acts as an NPR-17 blocker.
npr-17 is expressed in ASI neurons and nlp-24 is also expressed in ASI neurons (Figure 7—figure
supplement 2C) (Nathoo et al., 2001). This suggests that NLP-24 peptides may be secreted by and
act on ASI neurons in an autocrine manner. We also suspect that NLP-24 is secreted by other cells and
acts hormonally on ASI neurons, because, NLP-24::GFP expression is increased in intestine after
starvation (Figure 7—figure supplement 3). An NLP-24::mCherry fusion protein accumulates in
coelomocytes (Figure 7—figure supplement 2B), specialized cells for endocytosis and degradation
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Figure 5. Activities of NLP-24 peptides and opioid agonists on NPR-17. Opioid agonists and NLP-24 peptidemediated changes in intracellular calcium were measured with the calcium detector Fluo-4. (A) Calcium responses in
human embryonic kidney 293 (HEK-293) cells transfected with NPR-17 and Gα15. All compounds were tested at 1 μM.
Loperamide (μ agonist), SB205607 (δ agonist), U69593 (κ agonist) and GPYGYGamide activated NPR-17. Different from
0, *p < 0.05, **p < 0.01, ***p < 0.001, two-way ANOVA + sequential Bonferroni correction. (B) Dose-response curves of
HEK-293 cells transfected with NPR-17 and Gα15. Loperamide, U69593 and NLP-24 peptide GPYGYGamide induced
NPR-17 activation in a dose dependent manner, and these responses were suppressed by opioid blocker naloxone (10
μM). Responses were normalized to 1 μM loperamide. The loperamide effect is significant at p < 0.001, and the effects
of U69593 and GPYGYGamide at p < 0.01, two-way ANOVA + sequential Bonferroni correction. Pooling the results
from A and B, the effect of GPYGYGamide is significant at p < 0.001 (Stouffer’s weighted Z-score test).
DOI: 10.7554/eLife.06683.013

of secreted proteins (Fares and Grant, 2002), which have been found to accumulate other secreted
peptide signals (Sieburth et al., 2007; Lee and Ashrafi, 2008). Our result is thus consistent with the
idea that NLP-24 is a precursor for secreted peptides, supporting the idea that NLP-24 is secreted and
sensed by NPR-17 in ASI neurons.
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Figure 6. Activities of NLP-24 peptides and agonists on MOR-1, DOR-1 and KOR-1. Opioid agonist and NLP-24
peptide-mediated changes in intracellular calcium were measured by the calcium detector Fluo-4. Agonists and
peptides were tested at 1 μM. (A) Calcium responses in HEK-293 cell transfected with MOR-1 and Gα15. (B) Calcium
responses in HEK-293 cell transfected with DOR-1 and Gα15. (C) Calcium responses in HEK-293 cell transfected with
KOR-1 and Gα15. ***p < 0.001, **p < 0.01, *p < 0.05. (Two-way ANOVA with Bonferroni correction.) (D) Doseresponse curves of HEK-293 cells transfected with MOR-1 or KOR-1 and Gα15. NLP-24 peptide YGGYGamide
activated MOR-1and KOR-1, and these responses were suppressed by the opioid blocker naloxone (10 μM). MOR-1
responses were normalized to 1 μM loperamide and KOR-1 to 1 μM U69593. The effects of YGGYGamide on MOR-1
and KOR-1 are significant at p < 0.001 (two-way ANOVA).
DOI: 10.7554/eLife.06683.014

Together our results demonstrate that C. elegans has an endogenous opioid system, which
modulates pumping during starvation. But what is the purpose of pumping in the absence of food?
Following a suggestion by David Raizen (personal communication), we suggest that this pumping
helps worms discover food in the environment, even when their external senses are unable to reliably
detect it. According to this hypothesis, opioids help worms survive starvation by increasing the
probability of catching food. In essence, food-independent pumping is (or facilitates) exploration. This
is consistent with the finding that in many animals, including C. elegans, starvation increases
exploration (Dallman et al., 1999; Torres et al., 2002).
This hypothesis suggested that, in addition to increasing pumping to enhance the chance of
catching food, opioids might increase locomotion to enhance the chance of finding food. C. elegans
locomotion is tightly related to nutritional status (Shtonda and Avery, 2006; Ben Arous et al., 2009).
There are three potentially distinct locomotive states: roaming, dwelling, and quiescence (Fujiwara
et al., 2002; You et al., 2008). Roaming is the food-seeking behavior; worms roam when the food is
scarce. We therefore tested the effect of nlp-24 mutation on locomotion in starved worms. Wild type
spent 93% of the time roaming, but in nlp-24 mutants this was reduced to 69% (Figure 8). An nlp-24
transgene rescued the defect. Based on these results, we suggest that by increasing pumping and
increasing exploration opioids help worms survive starvation.
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Figure 7. ASI neurons are required for opioid-mediated feeding control. (A) Effect of naloxone on pumping. Worms
genetically engineered to lack ASI neurons were not affected. ASI neurons were genetically ablated by the
recCaspase method (Chelur and Chalfie, 2007; Beverly et al., 2011) (ASI−) ***Different from 0 mM, p < 0.001; N.S.
Figure 7. continued on next page
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Figure 7. Continued
not significantly different from 0 mM (two-way ANOVA, concentration effect). The effect of naloxone on wild-type is
significantly different from its effect on npr-17, p < 0.001 (two-way ANOVA, genotype × concentration interaction).
(B) npr-17 expression in ASI neurons is required for opioid-mediated feeding control. npr-17 mutants were not
affected by naloxone, but this phenotype was rescued with by expression of npr-17 under control of the ASI-specific
promoter gpa-4. ***Different from 0 mM, p < 0.001, N.S., not significantly different from 0 mM (two-way ANOVA,
concentration effect). The interaction between genotype and concentration is significant at p < 0.001 for Pges-1::
npr-17 rescued vs WT, but not Pnpr-17::npr-17 or Pgpa-4::npr-17 rescued. The interaction between genotype and
concentration is significant at p < 0.001 for Pnpr-17::npr-17 and Pgpa-4::npr-17 rescued vs npr-17, but not Pges-1::
npr-17 rescued. (C) Chronic effect of naloxone on pumping. Worms grown to adulthood with or without 10 mM
naloxone plate were then tested with or without 10 mM naloxone. ***p < 0.001; N.S. not significantly different. The
stimulatory effect of taking naloxone away from worms grown in the presence of naloxone is significant at p < 0.05.
(ANOVA + Tukey tests).
DOI: 10.7554/eLife.06683.015
The following figure supplements are available for figure 7:
Figure supplement 1. npr-17 in ASI neurons are required for opioid-mediated feeding control.
DOI: 10.7554/eLife.06683.016
Figure supplement 2. nlp-24 expression.
DOI: 10.7554/eLife.06683.017
Figure supplement 3. Starvation induces nlp-24 expression in intestine.
DOI: 10.7554/eLife.06683.018

Discussion
We hope as a result of these studies to establish C. elegans as an invertebrate genetic model for the
study of opioid signaling. Our results confirm previous indications that opioids have a long
evolutionary history. Several researchers have found evidence that the opioid system might exist in
invertebrates: peptides encoding opioids or opioid receptors were detected, and drugs such as
naloxone that act on opioid receptors induced biological responses (Harrison et al., 1994). We
confirm these results in C. elegans and add a crucial control: a mutant lacking the receptor fails to
respond. Furthermore, like vertebrate opioids, worm opioids have a role in feeding behavior. nlp-24
encodes endogenous opioids and npr-17 an opioid receptor, and together they act to regulate
feeding behavior. Opioids also participate in the immune system and pain mechanisms in vertebrates
(McCarthy et al., 2001). nlp-24 and npr-17 may have related functions in C. elegans. nlp-24
expression is down regulated by a pathogenic bacterium, Pseudomonas aeruginosa, and a fungus,
Drechmeria coniospora (Troemel et al., 2006; Pujol et al., 2008). npr-17 mediates ASH-mediated
aversive behavior (Harris et al., 2010), a C. elegans model for pain.
Harris et al. (2010) found that nlp-3 affects ASH-mediated aversion upstream of NPR-17, and
suggested therefore that NPR-17 might be an NLP-3 peptide receptor. We too found that nlp-3
mutation affects MC-independent pumping, although it had no effect on starved wild-type worms
(Figure 2—figure supplement 3). While we cannot exclude the possibility that NLP-3 peptides are
NPR-17 ligands, Harris et al.’s results are equally well explained by a model in which NLP-3 peptides
affect NPR-17 indirectly by affecting the release of NLP-24 peptides.
We showed that opioids stimulate pumping during starvation. We started with the hypothesis that
neuropeptides regulate pumping in the absence of MC activity. Thus, we performed experiments in
starved worms. Opioid agonists and antagonists modulated pumping in starved worms, and the
opioid mutant nlp-24 had decreased pumping in starvation. In the presence of food, in contrast, both
nlp-24 mutants (Figure 2—figure supplement 4) and egl-3 mutants (Figure 1A) showed the same
pumping rate as wild type. Nutritional state affected opioid activity: nlp-24 expression was increased
by starvation (Figure 2A). Likewise, food deprivation and feeding changes endogenous opioid activity
in mammals. In rats, food deprivation induces complex changes in the level of brain endogenous
opioids, especially in the hypothalamus (Vaswani and Tejwani, 1986). In addition, opioid signaling
may be involved in altering the hedonic taste/palatability of food in mammals (Bodnar, 2004).
Why does C. elegans need opioid signaling to control feeding during starvation? In a well-fed
worm, pumping depends on MC motor neurons, which are active only in the presence of food.
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Figure 8. nlp-24 stimulates roaming behavior in starved worms. Behavioral states of adult worms on plates without
food. A single worm was starved for 30 min, then recorded for 1 hr. Locomotion was analyzed as described
previously (Gallagher et al., 2013). Starvation increased roaming behavior in wild type. nlp-24 mutants had reduced
roaming behavior compared to wild type, and an nlp-24 transgene rescued this phenotype. N = 22 worms for wild
type, 27 for nlp-24 mutants, and 19 for nlp-24 rescued worms. All nlp-24 state probabilities are significantly different
from the corresponding probabilities for wild type and the rescued strain, p < 0.001, with the exception of the Q
state for nlp-24 vs wild type, for which p < 0.01. There are no significant differences between wild type and nlp-24
rescued. (Mann–Whitney U-test with sequential Bonferroni correction).
DOI: 10.7554/eLife.06683.019

But opioids modulated pumping independent of MC neurons: naloxone decreased pumping in eat-2
mutants, which lack MC neuromuscular transmission (McKay et al., 2004) (Figure 3—figure
supplement 2). We speculate that, like a baby whose first response to any new object is to put it in its
mouth, the worm cannot be sure if there is food around without taking some in. A well-fed worm
avoids this dangerous test, but a starving worm continually pumps at a low rate even in the absence of
food in order to detect any that might appear. Consistent with this, we found that opioids motivate
worms to seek food by stimulating locomotion as well as pumping.
Thus opioids make worms willing to search for food despite the high risk. Animals live in dynamic
environments where food availability is variable. For survival in this environment, food-seeking
behavior is important. Opioids help worms find food through risky pumping and exploration
behaviors. Thus endogenous opioids may help worms survive in dynamic environments.
Opioids stimulated pumping through ASI neurons (Figure 7). ASI neurons are activated by nutrition
and release DAF-7 TGF-β when the environment is favorable. daf-7 expression in ASI neurons regulates
fat accumulation and food intake (Greer et al., 2008). ASI neurons also stimulate roaming behavior
(Flavell et al., 2013). These results suggest that ASI neurons are important for modulating energy
balance and feeding behavior. In mammals opioid receptors are expressed in the hypothalamus, which
plays a central role in the control of food intake and the regulation of energy. Injection of opioid agonists
or antagonists into the hypothalamus modulates food intake (Jenck et al., 1987; Li et al., 2006; Naleid
et al., 2007). We suggest that opioids modulate C. elegans feeding through ASI neurons, similar to the
way vertebrate opioids modulate feeding through the hypothalamus.
Which pharyngeal neurons are involved in opioid signaling? Our lab did several suppressor screens
with slow pumping. From these screens, the most commonly mutated gene was slo-1. slo-1 mutations
enhance neurotransmitter release (Wang et al., 2001). This enhancement is particularly striking for M4
and M5, the motor neurons that synapse on TB (terminal bulb) muscle (Albertson and Thomson, 1976;
Chiang et al., 2006). We also screened for suppressors of the slow pumping and growth phenotypes of
eat-2; egl-3 mutants. 7/15 suppressors were new slo-1 mutations. These results are consistent with the
possibility that M4 might be involved in the opioid signaling response. We do not know yet how ASI
neurons communicate with pharyngeal neurons. The pharyngeal and extrapharyngeal nervous systems
are connected only by a bilateral pair of gap junctions between the extrapharyngeal RIP neurons and the
pharyngeal I1 neurons (Albertson and Thomson, 1976), and I1s are not necessary for MC-independent
pumping (Avery and Horvitz, 1989). This, together with the fact that ASI secretes several different
peptides, suggests that communication is likely to be humoral.
Heterologously expressed NPR-17 was activated by specific MOR-1 and KOR-1 agonists. These
results suggested that NPR-17 might be more similar to μ and κ type receptors than δ. We also tested
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pumping with these agonists. Among the three, loperamide induced nose muscle contraction similar
to that caused by fluoxetine (Choy and Thomas, 1999), so that we could not measure the pumping
rate. U69593 increased pumping in wild-type worms but not npr-17 mutants (Figure 9). These results
suggest that NPR-17 might be similar to the KOR but do not exclude similarity to μ as well. Vertebrate
opioid receptors are about 60% identical to each other (Chen et al., 1993). In BLAST results, NPR-17
showed 23% identity with MOR-1 and DOR-1 and 24% identity with KOR-1. The three vertebrate
receptors almost certainly diverged from each other well after any common ancestor of nematodes
and vertebrates, so NPR-17 is probably an ortholog of all three. Clearly, NPR-17 is not a close
homolog of any particular vertebrate opioid receptor. Rather, we suggest that NPR-17 and the
vertebrate receptors collectively derive from a common ancestor in which the outlines of opioid
system function had already appeared. Further, NPR-17 appears to be functionally closer to
vertebrate opioid receptors than any other molecularly characterized invertebrate receptor is.
We originally thought that NLP-24 might be related to opioids because it encodes peptides
containing YGGY, similar to the YGGF sequence common to vertebrate opioids. In fact, of the six
predicted NLP-24 peptides, YGGYGamide alone activated MOR-1 and KOR-1 expressed in human
embryonic kidney 293 (HEK-293) cells. But, to our surprise, YGGYGamide did not detectably activate
NPR-17 in the same system. In fact, the only peptide that worked was GPYGYGamide. By itself, this
result might cast doubt on the idea that NLP-24 and NPR-17 are components of the C. elegans opioid
system. The extreme version of this doubt would argue that NLP-24, like POMC, is a precursor for
multiple peptides that act on distinct unrelated receptors, and that it is essentially coincidence that
the NPR-17 ligand GPYGYGamide shares a precursor with the opioid YGGYGamide. But this idea fails
to explain multiple lines of data suggesting NPR-17 is a bona fide opioid receptor, namely: (1)
Heterologously expressed NPR-17 responds to opioid receptor agonists and the blocker naloxone. (2)
Naloxone blocks the response of NPR-17 to GPYGYGamide. (3) npr-17 is necessary for the behavioral
response of worms to opioid agonists and naloxone. (4) NPR-17 has sequence similarity to opioid
receptors. A more parsimonious explanation of the discrepancy is that in the HEK-293 expression
system, where we asked a single npr-17 product to work entirely through vertebrate proteins, we
failed to completely reconstitute its in vivo activity. Of course, these ideas are not mutually exclusive. It
may be that in the worm some form of NPR-17 does respond to YGGY-containing NLP-24 products,
and that NLP-24 produces products that act on other receptors as well.

Figure 9. Opioid agonist effects in C. elegans. The δ agonist SB205607 did not affect pumping. κ agonist U69594
stimulated pumping in starved wild-type worms but not npr-17 mutants. **p < 0.01. N.S. not significant. (Two-way
ANOVA).
DOI: 10.7554/eLife.06683.020
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Our study confirms with molecular genetic data the previous pharmacological evidence that an
invertebrate homolog of the vertebrate opioid system exists and has related functions. In the future,
we hope this will enable the discovery of new molecular pathways through which opioids act and
perhaps help to find ways to mitigate the side-effects that limit the usefulness of opiate drugs.

Materials and methods
Cultivation methods and strains
Worms were cultured routinely on NGMSR plates (Avery, 1993). All worms were maintained at 20˚C
on Escherichia coli strain HB101 unless indicated otherwise. The wild-type strain was C. elegans
variant Bristol, strain N2. The following mutant strains were used in this study: DA465 eat-2(ad465) II,
GR1328 egl-3(nr2090) V, KP1873 egl-3(nu349) V, DA2434 eat-2(ad465) II; egl-3(nu349) V, DA2435 eat2(ad465) II; egl-3(nr2090) V, DA2467 eat-2(ad465) II; nlp-3(tm3023) X, DA2456 nlp-24(tm2105) V,
DA2466 eat-2(ad465) II; nlp-24(tm2105) V, DA2457 npr-17(tm3210) III, DA2458 npr-17(tm3225) III,
DA2561 adEx2561[npr-17::GFP Punc-122::RFP], DA2582 npr-17(tm3210) III; adEx2561[Pnpr-17::npr17::GFP Punc-122::RFP], DA2583 npr-17(tm3225) III; adEx2561[Pnpr-17::npr-17::GFP Punc-122::RFP],
DA2586 npr-17(tm3210) III; adEx2586[Pgpa-4::npr-17::SL2::RFP Punc-122::RFP], DA2587 npr-17
(tm3210) III; adEx2587[Pges-1::npr-17::SL2::RFP Punc-122::RFP], DA2588 npr-17(tm3225) III;
adEx2588[Pgpa-4::npr-17::SL2::RFP Punc-122::RFP], DA2589 npr-17(tm3225) III; adEx2589[Pges-1::
npr-17::SL2::RFP Punc-122::RFP], DA2596 npr-17(tm3210) III; adEx2596[Pnlp-24::nlp-24::GFP Punc122::RFP], DA2597 npr-17(tm3225) III; adEx2597[Pnlp-24::nlp-24::GFP Punc-122::RFP], DA2557
adEx2557[Pnlp-24::nlp-24::mCherry Punc-122::GFP], DA2590 adEx2590[Pnlp-24::nlp-24::GFP Punc122::RFP], DA2591 adEx2591[Pnlp-24::nlp-24::GFP Punc-122::RFP], DA2592 adEx2592[Pnlp-24::GFP
Punc-122::RFP], DA2593 nlp-24(tm2105) V; adEx2593[Pnlp-24::nlp-24::GFP Punc-122::RFP], PY7505
oyIs84[Pgpa-4::TU813 Pgcy-27::TU814 Pgcy-27::eGFP Punc-122::DsRed] (Beverly et al., 2011)
PY7005 was gift from Piali Sengupta.

Molecular biology and transgenesis
Most DNA constructs were made using overlap-extension PCR (Hobert, 2002). Briefly, to fuse two or
more individual PCR products (PfuUltra High-Fidelity DNA Polymerase, stratagene, La Jolla, CA), we
amplified with oligonucleotides that included 5′ extensions complementary to the fusion target. Primers
for making these constructs are listed in Supplementary file 2. A transcriptional reporter for nlp-24 was
made by fusing the promoter of nlp-24 (−2262 to +1) to the coding sequence of GFP amplified from
pPD95.77 (Fire et al., 1990). For an nlp-24 translational reporter (Pnlp-24::nlp-24::GFP), the genomic
sequence of nlp-24 (−2760 to +316) was fused in frame to GFP followed by the unc-54 3′ UTR from
pPD95.77. For nlp-24 rescue and overexpression, we used an nlp-24 translational reporter. To make
NLP-24 fused with mCherry, the genomic sequence of nlp-24 (−2760 to +316) was fused in frame to
mCherry followed by the unc-54 3′ UTR from pAV1997 (Miedel et al., 2012). To make NLP-24::SL2::
GFP, we used a pJG7-psm-SL2-GFP vector (a gift from Dr Cori Bargmann). The genomic sequence of
nlp-24 (−3151 to +460) was ligated into the pJG7-psm-SL2-GFP vector. To make an npr-17 translational
reporter (Pnpr-17::npr-17::GFP), we amplified GFP from pPD95.77 and inserted this PCR product in the
genomic sequence of npr-17 (−5110 to +5545) before the stop codon, thus fusing GFP with the npr-17
3′ UTR (+5548 to +6524). For site specific expression of npr-17, we used a vector from Douglas S Kim
based on pSM into which was inserted SL2::RFP and the unc–54 3′ UTR. First, npr-17 cDNA was
amplified and ligated into the pSM-SL2::RFP vector as an XmaI/NheI fragment. Then, to express npr-17
in the ASI neurons, 2.5 kb of gpa-4 promoter amplified from N2 genomic DNA was cloned into this pSM
npr-17 SL2::RFP construct using BamHI and NotI. To express npr-17 in the intestine, 3 kb of ges-1
promoter was amplified from N2 genomic DNA and inserted into the pSM npr-17 SL2::RFP construct
using BamHI and NotI sites. To express in mammalian cell culture, npr-17 cDNA was amplified from N2
cDNA using MyTaq DNA polymerase (Bioline, Taunton, MA) to generate PCR products with a 5′ Kozak
consensus sequence and 3′-A overhang. This product was inserted into the PCDNA3.3 TOPO TA
cloning vector (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions.
Transgenic animals were generated by microinjection using a Zeiss Axio Observer A1 DIC
microscope equipped with an Eppendorf Femtojet microinjection system. For the injection marker, we
used Punc-122::GFP or Punc-122::RFP. 50 ng/μl of the fused construct or the plasmid was injected
together with 50 ng/μl of the injection marker.
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Measurement of pharyngeal pumping rates in starved worms
Worms were grown on NGMSR plates seeded with E. coli HB101 until the first day of adulthood, then
transferred to NGMSR plates without food, After 1 hr at 20˚C, we measured the pumping rate by counting
pharyngeal grinder movements for 1 min using a Wild M410 dissecting microscope at 64× magnification.
For drug experiments, we prepared drug-containing plates by spreading 300 μl of a 10× aqueous drug
solution on a 35 mm diameter plate, then waiting at least 3 hr for the drug to diffuse into the agar. Firstday adults were then transferred to these plates and incubated for 1 hr at 20˚C before counting.

RNAi screen
RNAi was induced by feeding as described (Timmons et al., 2001), with the following modifications.
Standard NGMSR agar was supplemented with 25 μg ml−1 carbenicillin and 1 mM isopropyl β-D-1thiogalactopyranoside and poured into 12-well plates. E. coli HT115 carrying the appropriate RNAi
clones was grown in LB containing 100 μg ml−1 carbenicillin at 37˚C overnight, then 50 μl drops were
seeded onto plates, making sure the culture dried within 1–2 hr, and induced at 37˚C for 12 hr. Fourth
stage larval (L4) worms were then transferred to the plates (3 worms per well) and allowed to grow to
young adulthood at 20˚C for approximately 4 days. We tested a total of 115 different neuropeptide
genes. We used the Ahringer RNAi library for 91 neuropeptide clones (Kamath and Ahringer, 2003).
For 24 neuropeptides, we cloned PCR-amplified exons into the L4440 vector. Primers for making
these constructs are listed in Supplementary file 3.

qRT-PCR
Total RNA was isolated using TRIzol (Life Technologies, Carlsbad, CA), and reverse transcribed using the
Tetro cDNA Synthesis Kit (Bioline). The cDNA was quantified using Nanodrop (ND-1000) and used in
qRT-PCR reactions. These reactions were performed on a CFX96 Real-Time PCR Detection System using
the SensiMixPlus SYBR & Fluorescein Kit (Bioline). We used 500 ng of cDNA per sample in a total volume
of 25 μl. Target genes were amplified using specific primers. Amplification and expression analysis were
performed in triplicate. mRNA levels in the tested strains were normalized with ama-1, a housekeeping
gene. For quantification, we used the Delta–delta Ct method. Primers were nlp-3 Forward
TGTGTCTACTCTGCTCCCTATG, nlp-3 Backward TGATCATGTCTGGACGGAAAG for nlp-3 and nlp24 Forward ACGGAGGTGGACGTTATGGA, nlp-24 Backward GAGACCGCCTCCTCCGTAT for nlp-24.

Cell culture and transfection
HEK-293 cells (ATCC, Manassas, VA) were cultured in DMEM supplemented with 10% FBS at 37˚C in
a humidified atmosphere containing 5% CO2. For stable cell line generation, we transfected with a 1:1
ratio of pcDNA3.3 containing 1 μg npr-17 and Gα15 cDNA (promiscuous G protein 15, Missouri S&T
cDNA Resource Center) using X-tremeGENE HP DNA transfection reagent (Roche, Switzerland). Cells
were seeded into 10 cm dishes and antibiotic (500 μg/ml G418) was added to the culture medium the
next day. The selection medium was changed every 3 days until colonies formed. A single colony was
picked, expanded, and tested by calcium imaging. Stable cell lines expressing human opioid receptor
MOR-1, DOR-1 and KOR-1 were constructed similarly. MOR-1, DOR-1 and KOR-1 plasmids were
provided by the Duke University GPCR Assay Bank.

Calcium imaging
HEK-293 cells cotransfected with NPR-17, MOR-1, DOR-1 or KOR-1 receptors and Gα15 were
plated onto 35 mm MatTek glass bottom dishes for calcium imaging. When they reached 70–80%
confluency calcium imaging was conducted using the Fluo-4 Direct Calcium assay kit (Molecular
Probes, Carlsbad, CA). The cells were loaded with Fluo-4 Direct Calcium reagent and incubated at
37˚C for 50 min. For naloxone treatment, 10 μM naloxone was added in the Fluo-4 Direct Calcium
reagent before incubation. Synthetic NLP-24 peptides (all synthesized with amidated C-termini),
opioid agonists, and blockers diluted in HBSS (Hank’s Balanced Salt Solution) buffer were applied to
the cell for 10 s, and fluorescence at 530 nm was monitored (excitation wavelength 470 nm) with
a Zeiss Axio Observer A1 microscope and ZEN software. Experiments were conducted on three
plates for each condition on three different days. Fluorescence was quantified using ImageJ. We
imported images using the ImageJ Bio-Formats plugin and subtracted background, then measured
the mean Integrated Density.
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Locomotion assays
L4 worms were picked to an HB101-seeded NGMSR plate and given 12 hr to develop to adulthood.
Adult worms were transferred to 6 cm NGMSR plates without food and incubated for 30 min. After 30
min, a single starved worm was then transferred to an individual 3.5 cm plate and its behavior
recorded as described previously (Gallagher et al., 2013b). We used a 10 mm copper ring to
constrain the worm. The light was then turned on and video capture proceeded at 1 frame/s for 1 hr.
Recordings were made on a modified version of the nine-worm recording station described by
Shtonda and Avery (2006) in which the worms were imaged through Computer MLM3X-MP macro
zoom lenses onto Pointgrey GRAS-14S5M-C digital cameras. We used ImageJ to get x, y coordinates.
We inverted each image and subtracted background. The light/dark threshold was adjusted to find
the outline of the worm then we determined the coordinates of the worm centroid using the ‘Analyze
Particles’ command in ImageJ. Finally, we used HMM analysis to define locomotive behavioral states
(Gallagher et al., 2013a).

Statistical analysis
Pumping rates were tested for statistically significant effects by ANOVA and corrected for
multiple testing by the Dunnett, Tukey, or sequential Bonferroni methods, as appropriate.
Interactions (for instance, the difference between the effects of morphine and naloxone on wildtype and npr-17 in Figure 2), were tested by two-way ANOVA. Gene expression (Figure 2A) was
tested by the interaction between gene (ama-1, nlp-3, or nlp-24) and nutritional state (well-fed
or starved), with well-fed ama-1 as the base case. These tests were carried out on C t
measurements, not gene expression levels, since gene expression measurements are typically
heteroscedastic.
Calcium imaging results were more complicated. In each experiment, a series of measurements
was made of the effects of different drugs or drug concentrations. All measurements in a series were
related by the use of cells sampled from the same population. Each series also included a blank in
which buffer was added. For each condition, we first measured base fluorescence (f0), then added
drug and measured fluorescence after 1 min (f1). We then pooled all the series measuring a given
effect and tested log (f1/f0) in a two-way ANOVA with series and drug as the factors, no interaction,
and the blank as the base case. This effectively normalizes each measurement to the blank in its own
series and tests the residues for drug effects. Particularly for Figure 5B and Figure 6D this test is
conservative, since it makes no use of the normalization to the maximal effect measured with
loperamide or U69593.
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